"The company plans to explore mRNA in other respiratory viruses, including medically appropriate vaccines combinations that could provide protection against more than one respiratory virus, as well as expand to develop mRNA technology in oncology, and genetic diseases."
“The COVID-19 pandemic allowed us to deliver on the immense scientific opportunity of mRNA. Influenza remains an area where we see a need for vaccines which could result in improved efficacy in any given season,
and we believe mRNA is the ideal technology to take on this challenge to transform global health outcomes.”
Am I the only one who sees that mRNA is a newly created Pharma gold rush?
Well, we better check "facts" from the #Pfizer Q3 2021 Earnings Deck.
Expected vaccine sales in 2022 based just on contracts from 2021: $29 Billion.
More "Engagement" with the Govs regarding "Potential Additional Order for 2022" in progress.
Just that you know why you're required to apply for a booster, or you're locked down.
What is quite funny is the fact that #PFE#Pfizer is using its competitor #Moderna#MRNA to it's advantage mentioning that "Alternate mRNA vaccine paused" in a few countries.
Worth attention are medicines with the highest sales increase.
2/ A bit of history:
- Nazi party was democratically elected.
- Nazi party controlled all Media and narrative.
- Population was encouraged to public shaming
- Anger of the population for the state of the country was aimed at Jews.
- They were segregated.
3/ - Their basic freedoms revoked.
- Stripped from the citizenship.
- Property seized
- Emigration made impossible
- Deportation and extermination is just the last step.
"...company plans to explore mRNA in other respiratory viruses, including medically appropriate vaccines combinations that could provide protection against more than one respiratory virus, as well as expand to develop mRNA technology in oncology, and genetic diseases."
“The COVID-19 pandemic allowed us to deliver on the immense scientific opportunity of mRNA...
...and we believe mRNA is the ideal technology to take on this challenge to transform global health outcomes.”